Latest Earnings Analysis
-
Artivion (AORT) Q3 2023: Stent Graft Growth Hits 22% as Clinical Data Drives Market Share Momentum
November 02, 2023 · AORT
-
Allstate (ALL) Q3 2023: Auto Rate Actions Top 26%, Margin Repair Drives Strategic Pivot
November 02, 2023 · ALL
-
Black Hills (BKH) Q3 2023: Net Debt Ratio Falls 300bps as Balance Sheet Strengthening Takes Priority
November 02, 2023 · BKH
-
Belden (BDC) Q3 2023: Orders Drop 19% as Channel Destocking and Industrial Weakness Deepen Downturn
November 02, 2023 · BDC
-
BioCryst (BCRX) Q3 2023: Orladeyo U.S. Patient Base Surpasses 1,000, Locking in Linear Growth Path
November 02, 2023 · BCRX
-
Baxter (BAX) Q3 2023: Operating Margin Rises 200bps Sequentially as Segment Realignment Drives Efficiency
November 02, 2023 · BAX
-
Booking Holdings (BKNG) Q3 2023: Alternative Accommodations Jump 24%, Pushing Direct App Bookings Past 50%
November 02, 2023 · BKNG
-
BlackLine (BL) Q3 2023: ARR Over $1M Accounts Rise to 55, Spotlighting Enterprise Expansion
November 02, 2023 · BL
-
Bandwidth (BAND) Q3 2023: Commercial Messaging Jumps 51% as Maestro Platform Gains Early Traction
November 02, 2023 · BAND
-
American Water Works (AWK) Q3 2023: $2B CapEx Plan Expansion Anchors 8% Rate Base Growth Trajectory
November 02, 2023 · AWK
-
Autolus Therapeutics (AUTL) Q3 2023: Nucleus Facility Validated for 2,000 Annual Batches, Unlocking Commercial Launch Readiness
November 02, 2023 · AUTL
-
AVNT Q3 2023: Margin Expansion Offsets 15% Volume Decline as Europe Turns Positive
November 02, 2023 · AVNT
-
AUPH Q3 2023: Lupkynis Net Revenue Jumps 60% as Persistency, Guidelines, and Globalization Drive Next Phase
November 02, 2023 · AUPH
-
Alnylam (ALNY) Q3 2023: Collaboration Revenue Surges $400M as ATTR Franchise Expands
November 02, 2023 · ALNY
-
Allient (ALNT) Q3 2023: Industrial Sales Surge 32% as Backlog Hits $310M, Margin Record Set
November 02, 2023 · ALNT
-
Allogene (ALLO) Q3 2023: $498M Cash Runway Extends Through Key 2024 Data Readouts
November 02, 2023 · ALLO
-
Alpha Metallurgical Resources (AMR) Q3 2023: $940M Buyback Shrinks Share Count 28% as Pure-Play Met Focus Solidifies
November 02, 2023 · AMR
-
Bausch Health (BHC) Q3 2023: Organic Growth Guidance Raised to 6% as Pipeline and Consumables Drive Durable Upside
November 02, 2023 · BHC
-
AMSC (AMSC) Q2 2023: 30% Backlog Growth Anchors Multi-Segment Margin Expansion
November 02, 2023 · AMSC
-
AVIAT Networks (AVNW) Q1 2024: North America Private Network Bookings Hit Record, Accelerating Share Gains
November 01, 2023 · AVNW
-
Airbnb (ABNB) Q3 2023: Listings Surge 19% as Global Supply Expansion Outpaces Demand
November 01, 2023 · ABNB
-
Aurora Innovation (AUR) Q3 2023: $850M Capital Raise Extends Runway Past 2025 as Safety Milestone Nears
November 01, 2023 · AUR
-
BioMarin (BMRN) Q3 2023: Voxzogo Surges 165% as Roctavian Network Build Sets Up $3B Revenue Path
November 01, 2023 · BMRN
-
AWRE Q3 2023: Recurring Revenue Rises 83% Since 2019, Accelerating Platform Leverage
November 01, 2023 · AWRE
-
Amarin (AMRN) Q3 2023: OpEx Falls $14M as Europe Lags, U.S. Cash Engine Persists
November 01, 2023 · AMRN
-
Butterfly Network (BFLY) Q3 2023: Software Mix Jumps to 43% as Platform Pivot Gains Traction
November 01, 2023 · BFLY
-
AtriCure (ATRC) Q3 2023: Open Ablation Drives 20% Franchise Growth as R&D Outpaces SG&A
November 01, 2023 · ATRC
-
Amwell (AMWL) Q3 2023: $180M DHA Task Order Expands Government Pipeline and Subscription Visibility
November 01, 2023 · AMWL
-
Avnet (AVT) Q1 2024: Inventory Rises $290M as Supply Chain Initiatives Delay Correction
November 01, 2023 · AVT
-
Axalta (AXTA) Q3 2023: Mobility EBIT Jumps 900%, Margin Expansion Signals Structural Reset
November 01, 2023 · AXTA
-
Astec Industries (ASTE) Q3 2023: Litigation Charge Drives 200bps EBITDA Margin Contraction Amid Margin Gains
November 01, 2023 · ASTE
-
Bright Horizons (BFAM) Q3 2023: Backup Care Surges 32% as Enrollment Recovery Broadens
November 01, 2023 · BFAM
-
Atomera (ATOM) Q3 2023: MST Adoption Triggers $300K Milestone, Expanding Licensing Pathways
November 01, 2023 · ATOM
-
Avista (AVA) Q3 2023: CapEx Rises to $500M for 2024, Clean Energy and Grid Modernization in Focus
November 01, 2023 · AVA
-
Alkami Technology (ALKT) Q3 2023: Contract Backlog Climbs 31% as Bank Demand Accelerates
November 01, 2023 · ALKT
-
Atara Biotherapeutics (ATRA) Q3 2023: $640M TAPCEL Deal Extends Runway, Refocuses Pipeline on Allogeneic Cell Therapies
November 01, 2023 · ATRA
-
Avanos (AVNS) Q3 2023: Digestive Health Up 10.5% as Pain Recovery Stabilizes
November 01, 2023 · AVNS
-
BBSI (BBSI) Q3 2023: Staffing Revenue Drops 25% as PEO Growth Offsets Client Hiring Slump
November 01, 2023 · BBSI
-
Builders FirstSource (BLDR) Q3 2023: Value-Added Mix Hits 51% as Multifamily Tailwind Moderates
November 01, 2023 · BLDR
-
Bally’s (BALY) Q3 2023: Chicago Temp Casino Adds $50M+ EBITDAR Run-Rate, Reshaping Growth Path
November 01, 2023 · BALY
-
Assurant (AIZ) Q3 2023: Housing EBITDA Doubles, Margin Expansion Outpaces Macro Headwinds
November 01, 2023 · AIZ
-
Apollo Global Management (APO) Q3 2023: Inflows Reach $33B as Private Credit and Origination Platforms Accelerate
November 01, 2023 · APO
-
Alight (ALIT) Q3 2023: BPaaS Bookings Jump 26% as Platform Model Drives Margin Expansion
November 01, 2023 · ALIT
-
Amcor (AMCR) Q1 2024: $500M Inventory Drawdown Supports Cash Flow Resilience Amid 8% Volume Decline
November 01, 2023 · AMCR
-
Blackbaud (BLKB) Q3 2023: Rule of 40 Surges to 41.6% as Recurring Revenue Expands
November 01, 2023 · BLKB
-
AGNC (AGNC) Q3 2023: Book Value Drops 11% as Agency MBS Spreads Hit Pandemic-Era Wides
October 31, 2023 · AGNC
-
Amgen (AMGN) Q3 2023: Rare Disease Platform Adds $945M, Lifting Global Growth Ambitions
October 31, 2023 · AMGN
-
AMETEK (AME) Q3 2023: EIG Margins Surge 360bps, MedTech Exposure Doubles With $1.9B Paragon Deal
October 31, 2023 · AME
-
AMD (AMD) Q3 2023: MI300 GPU Revenue to Exceed $2B in 2024, Signaling Data Center Inflection
October 31, 2023 · AMD
-
ALX Q3 2023: $3.2B Liquidity Shields Portfolio as Office Leasing Pipeline Hits 1.8M Square Feet
October 31, 2023 · ALX